We are live on
!
Find out more
Orbis Allan Gray Portfolio holdings
AUM
$29.1B
Turnover
17.48%
1-Year Est. Return
60.8%
This Fund
S&P 500
This Quarter
Est. Return
+13.86%
1 Year Est. Return
+60.8%
3 Year Est. Return
+154.65%
5 Year Est. Return
+203.47%
10 Year Est. Return
+909.03%
AUM
$14.3B
AUM Growth
+$786M
(+5.8%)
Cap. Flow
-$887M
Cap. Flow
% of AUM
-6.19%
Top 10 Holdings %
Top 10 Hldgs %
67.76%
Holding
67
New
7
Increased
20
Reduced
21
Closed
4
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$314M |
| 2 |
Fomento Económico Mexicano
FMX
|
+$174M |
| 3 |
British American Tobacco
BTI
|
+$135M |
| 4 |
Altria Group
MO
|
+$122M |
| 5 |
APA Corp
APA
|
+$63.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$714M |
| 2 |
NetEase
NTES
|
+$302M |
| 3 |
XPO
XPO
|
+$161M |
| 4 |
Dollar General
DG
|
+$107M |
| 5 |
Berry Global Group, Inc.
BERY
|
+$93.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 32.72% |
| 2 | Healthcare | 21.11% |
| 3 | Industrials | 13.77% |
| 4 | Consumer Staples | 7.32% |
| 5 | Energy | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Peabody Energy
BTU
$2.93B
| $3.98M | 0.03% |
436,354
| – | – |
2017 Q4
8 quarters
|
|
52
Grupo Cibest SA
CIB
$23.1B
| $3.9M | 0.03% |
71,174
| – | – |
2017 Q2
10 quarters
|
|
53
Ingredion
INGR
$6.13B
| $3.76M | 0.03% |
40,462
+24,885
| +160% | +$2.09M |
2019 Q3
1 quarter
|
|
54
Humana
HUM
$51.9B
| $3.34M | 0.02% |
9,107
| – | – |
2019 Q2
2 quarters
|
|
55
Citigroup
C
$207B
| $2.72M | 0.02% |
34,098
| – | – |
2016 Q1
15 quarters
|
|
56
Walt Disney
DIS
$191B
| $2.11M | 0.01% |
14,588
+1,334
| +10% | +$186K |
2019 Q1
3 quarters
|
|
57
Youdao
DAO
$2.23B
| $2.11M | 0.01% |
+149,641
| New | +$2.1M |
2019 Q4
0 quarters
|
|
58
Chevron
CVX
$430B
| $1.87M | 0.01% |
15,504
| – | – |
2019 Q2
2 quarters
|
|
59
Gildan
GIL
$7.78B
| $1.39M | 0.01% |
+47,015
| New | +$1.38M |
2019 Q4
0 quarters
|
|
60
Nike
NKE
$55.2B
| $1.38M | 0.01% |
13,617
-7,990
| -37% | -$753K |
2017 Q2
10 quarters
|
|
61
CarMax
KMX
$7.47B
| $1.34M | 0.01% |
15,297
+8,058
| +111% | +$758K |
2019 Q3
1 quarter
|
|
62
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$155B
| $616K | ﹤0.01% |
83,138
| – | – |
2016 Q1
15 quarters
|
|
63
Liberty Latin America Class C
LILAK
$1.6B
| $604K | ﹤0.01% |
36,256
| – | – |
2016 Q1
15 quarters
|
|
64
Alibaba
BABA
$276B
| – | – |
-465,226
| Closed | -$77.8M | – |
|
65
McDonald's
MCD
$172B
| – | – |
-3,175
| Closed | -$682K | – |
|
66
Motorola Solutions
MSI
$75.5B
| – | – |
-6,741
| Closed | -$1.15M | – |
|
|
CELG
67
DELISTED
Celgene Corp
CELG
| – | – |
-7,187,955
| Closed | -$714M | – |
|
Similar funds
Orbis Allan Gray's Q4 2019 Portfolio in Review
As of Q4 2019, Orbis Allan Gray held 67 positions worth $14.3B, up 5.8% from $13.5B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Orbis Allan Gray withdrew a net $887M in Q4 2019, closing 4 positions and reducing 21 holdings. Its most notable exit was Celgene Corp, an estimated $714M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Orbis Allan Gray opened a new position in Bristol-Myers Squibb worth $352M.
- Orbis Allan Gray's largest Q4 2019 buy was Bristol-Myers Squibb: 5,481,869 shares worth $352M.
- Orbis Allan Gray added most to Fomento Económico Mexicano in Q4 2019, an estimated $174M increase.
- Orbis Allan Gray's biggest Q4 2019 reduction was NetEase, cutting an estimated $302M.
- Orbis Allan Gray fully exited Celgene Corp in Q4 2019, selling an estimated $714M.
- Orbis Allan Gray's ten largest holdings make up 68% of its $14.3B portfolio in Q4 2019.
- Orbis Allan Gray opened 7 new positions and closed 4 in Q4 2019.
- Orbis Allan Gray's portfolio value rose 5.8% quarter-over-quarter to $14.3B.
Based on Orbis Allan Gray's 13F filing for Q4 2019, filed 14 Feb 2020.